In vitro studies have shown that 5-Aza-CdR, a DNA methyltransferase 1 (DNMT1) inhibitor, could induce cell death and apoptosis of pancreatic cancer cells by reactivation of RASSF1A and upregulation of Bax genes [45]. This evidence concerns the gene RASSF1 and pancreatic neoplasm.